Khalid Elsaafien1, Annette D de Kloet2,3,4, Eric G Krause1,3,4, Colin Sumners5,6,7. 1. Department of Pharmacodynamics, University of Florida College of Pharmacy, Gainesville, FL, USA. 2. Department of Physiology and Functional Genomics, College of Medicine, University of Florida, Gainesville, FL, USA. 3. Center for Integrative Cardiovascular and Metabolic Diseases, University of Florida, Gainesville, FL, USA. 4. Evelyn F. and William L. McKnight Brain Institute, University of Florida, Gainesville, FL, USA. 5. Department of Physiology and Functional Genomics, College of Medicine, University of Florida, Gainesville, FL, USA. csumners@ufl.edu. 6. Center for Integrative Cardiovascular and Metabolic Diseases, University of Florida, Gainesville, FL, USA. csumners@ufl.edu. 7. Evelyn F. and William L. McKnight Brain Institute, University of Florida, Gainesville, FL, USA. csumners@ufl.edu.
Abstract
PURPOSE OF REVIEW: To review recent data that suggest opposing effects of brain angiotensin type-1 (AT1R) and type-2 (AT2R) receptors on blood pressure (BP). Here, we discuss recent studies that suggest pro-hypertensive and pro-inflammatory actions of AT1R and anti-hypertensive and anti-inflammatory actions of AT2R. Further, we propose mechanisms for the interplay between brain angiotensin receptors and neuroinflammation in hypertension. RECENT FINDINGS: The renin-angiotensin system (RAS) plays an important role in regulating cardiovascular physiology. This includes brain AT1R and AT2R, both of which are expressed in or adjacent to brain regions that control BP. Activation of AT1R within those brain regions mediate increases in BP and cause neuroinflammation, which augments the BP increase in hypertension. The fact that AT1R and AT2R have opposing actions on BP suggests that AT1R and AT2R may have similar opposing actions on neuroinflammation. However, the mechanisms by which brain AT1R and AT2R mediate neuroinflammatory responses remain unclear. The interplay between brain angiotensin receptor subtypes and neuroinflammation exacerbates or protects against hypertension.
PURPOSE OF REVIEW: To review recent data that suggest opposing effects of brain angiotensin type-1 (AT1R) and type-2 (AT2R) receptors on blood pressure (BP). Here, we discuss recent studies that suggest pro-hypertensive and pro-inflammatory actions of AT1R and anti-hypertensive and anti-inflammatory actions of AT2R. Further, we propose mechanisms for the interplay between brain angiotensin receptors and neuroinflammation in hypertension. RECENT FINDINGS: The renin-angiotensin system (RAS) plays an important role in regulating cardiovascular physiology. This includes brain AT1R and AT2R, both of which are expressed in or adjacent to brain regions that control BP. Activation of AT1R within those brain regions mediate increases in BP and cause neuroinflammation, which augments the BP increase in hypertension. The fact that AT1R and AT2R have opposing actions on BP suggests that AT1R and AT2R may have similar opposing actions on neuroinflammation. However, the mechanisms by which brain AT1R and AT2R mediate neuroinflammatory responses remain unclear. The interplay between brain angiotensin receptor subtypes and neuroinflammation exacerbates or protects against hypertension.
Authors: T Ichiki; P A Labosky; C Shiota; S Okuyama; Y Imagawa; A Fogo; F Niimura; I Ichikawa; B L Hogan; T Inagami Journal: Nature Date: 1995-10-26 Impact factor: 49.962
Authors: Javier E Stern; Sookjin Son; Vinicia C Biancardi; Hong Zheng; Neeru Sharma; Kaushik P Patel Journal: Hypertension Date: 2016-10-03 Impact factor: 10.190
Authors: Prashant J Ruchaya; Guilherme F Speretta; Graziela Torres Blanch; Hongwei Li; Colin Sumners; José V Menani; Eduardo Colombari; Débora S A Colombari Journal: Neuropeptides Date: 2016-07-20 Impact factor: 3.286
Authors: Jasenka Zubcevic; Monica M Santisteban; Pablo D Perez; Rebeca Arocha; Helmut Hiller; Wendi L Malphurs; Luis M Colon-Perez; Ravindra K Sharma; Annette de Kloet; Eric G Krause; Marcelo Febo; Mohan K Raizada Journal: Front Physiol Date: 2017-08-31 Impact factor: 4.566
Authors: U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners Journal: Pharmacol Rev Date: 2022-10 Impact factor: 18.923
Authors: Krzysztof Mińczuk; Marta Baranowska-Kuczko; Anna Krzyżewska; Eberhard Schlicker; Barbara Malinowska Journal: Int J Mol Sci Date: 2022-06-06 Impact factor: 6.208
Authors: Sarah B Scheinman; Steve Zaldua; Adedoyin Dada; Kateryna Krochmaliuk; Katherine Dye; Felecia M Marottoli; Gregory R J Thatcher; Leon M Tai Journal: Front Neurosci Date: 2021-02-10 Impact factor: 4.677